Prioritizing delivery of cancer treatment during a COVID19 lockdown - the experience of a clinical oncology service in India
Indranil Mallick(Tata Medical Center), Sanjoy Chatterjee(Tata Medical Center), B. Arun(Tata Medical Center), Siddharth Arora(Tata Medical Center), Vezokhoto Phesao(Tata Medical Center), Tapesh Bhattacharyya(Tata Medical Center), Shaurav Maulik(Tata Medical Center), Love Goyal(Cancer Research UK), Rohit Sasidharan(Tata Medical Center), Subecha Bhushal(Tata Medical Center), Rimpa Basu Achari(Tata Medical Center), Saheli Saha(Tata Medical Center), Vishnu Lal(Tata Medical Center), Samarth Chhatbar(Tata Medical Center), Shweta Baral(Tata Medical Center), Santam Chakraborty(Tata Medical Center), Anurupa Mahata(Tata Medical Center), S. Mandal(Tata Medical Center), Sriram Prasath(Tata Medical Center), Moses Arunsingh(Tata Medical Center)
Cited by 1
Related Papers
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
|Annals of Oncology|2022|138
Life Cycle Assessment of Solar Photovoltaic Microgrid Systems in Off-Grid Communities
|Environmental Science & Technology|2016|87
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma
|Annals of Oncology|2024|33
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India
|JCO Global Oncology|2021|11
Radiotherapy intensification for atypical and malignant meningiomas: A systematic review
|Neuro-Oncology Practice|2023|7